Skip to main content

Advertisement

SpringerLink
Log in

Serum markers of bone turnover in dialyzed patients separated according to age

  • Original Article
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

Bone metabolism changes with aging in healthy population. Our aim was to determine serum markers of bone turnover in dialysis patients separated according to age.

Methods

Peritoneal dialysis (PD) or hemodialysis (HD) patients were divided into two groups. Group I (n = 30) consisted of patients older than 65 years. Patients at the age less or equal 65 years were included in group II (n = 37). In all patients we determined serum concentration of intact parathyroid hormone (iPTH), cyclase activating parathyroid hormone (CAP), osteoprotegrin (OPG) and osteoprotegrin ligand (OPGL). Cyclase inactive parathyroid hormone (CIP) was calculated. Healthy volunteers (n = 13) at the age of 42.1 years (range 23.5–70.9 years) served as controls.

Results

When results of dialysis patients were adjusted to gender, dialysis modality and duration, group I revealed significantly lower iPTH (113.0, 10.3–606.3 pg/ml), CAP (70.0, 6.5–442.6 pg/ml) and CIP (53.3, 3.3–214.4 pg/ml) than group II (310.6, 13.7–1266.9 pg/ml for iPTH; 205.0, 9.3–887.9 pg/ml for CAP; 76.0, 2.4–399.0 pg/ml for CIP), but this group showed significantly higher serum OPG (7.39, 1.52–15.84 pg/ml) than group II (5.45, 0.95–16.47 pg/ml) and controls (2.17, 1.05–3.95 pg/ml). Only patients of group II showed significantly higher iPTH, CAP and CIP than controls (34.9, 18.9–76.9 pg/ml; 24.3, 11.2–42.6 pg/ml, 12.0, 1.0–34.2 pg/ml, respectively for iPTH, CAP and CIP).

Conclusion

Our results suggest that age over 65 years is a risk factor for low bone turnover in dialyzed patients. An increase in serum OPG probably reflects a paracrine mechanism of bone cells to compensate for age dependent bone loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CAP:

Cyclase activating parathyroid hormone

CIP :

Cyclase inactive parathyroid hormone

HD :

Hemodialysis

IL :

Interleukin

iPTH :

Intact parathyroid hormone

OPG :

Osteoprotegrin

OPGL :

Osteoprotegrin ligand

PD :

Peritoneal dialysis

PGE2 :

Prostaglandin E2

TNF :

Tumor necrosis factor

References

  1. ES Oh EJ Rhee KW Oh WY Lee KH Baek KH Yoon (2005) ArticleTitleCirculating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women Metabolism 54 49–54 Occurrence Handle15562379 Occurrence Handle1:CAS:528:DC%2BD2cXhtVansbrN Occurrence Handle10.1016/j.metabol.2004.08.005

    Article  PubMed  CAS  Google Scholar 

  2. A Fahrleitner-Pammer H Dobnig C Piswanger-Soelkner C Bonelli HP Dimai G Leb (2003) ArticleTitleOsteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status Wien Klin Wochenschr 115 291–297 Occurrence Handle12793029 Occurrence Handle1:CAS:528:DC%2BD2cXltVen Occurrence Handle10.1007/BF03040334

    Article  PubMed  CAS  Google Scholar 

  3. L Pulsatelli P Dolzani T Silvestri P Caraceni A Facchini G Ravaglia (2004) ArticleTitleSoluble receptor activator of nuclear factor- kappaB ligand (sRANKL)/osteoprotegerin balance in ageing and age-associated diseases Biogerontology 5 119–127 Occurrence Handle15105586 Occurrence Handle1:CAS:528:DC%2BD2cXjtlCgs70%3D Occurrence Handle10.1023/B:BGEN.0000025075.04136.ec

    Article  PubMed  CAS  Google Scholar 

  4. JM Liu HY Zhao G Ning YJ Zhao Y Chen LZ Zhang (2004) ArticleTitleThe relationships between changes of serum osteoprotegerin, nuclear factor-kappa B ligand receptor activator, and age, menopause, bone biochemical markers and bone mineral densities in women aged 20–75 Zhonghua Nei Ke Za Zhi 43 447–450 Occurrence Handle15312444 Occurrence Handle1:CAS:528:DC%2BD2cXot1Kqsr4%3D

    PubMed  CAS  Google Scholar 

  5. T Ueland K Brixen L Mosekilde L Mosekilde A Flyvbjerg J Bollerslev (2003) ArticleTitleAge-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study J Clin Endocrinol Metab 88 1014–1018 Occurrence Handle12629078 Occurrence Handle1:CAS:528:DC%2BD3sXit1egtbk%3D Occurrence Handle10.1210/jc.2002-020977

    Article  PubMed  CAS  Google Scholar 

  6. S Kudlacek B Schneider W Woloszczuk P Pietschmann R Willvonseder (2003) ArticleTitleSerum levels of osteoprotegerin increase with age in a healthy adult population Bone 32 681–686 Occurrence Handle12810175 Occurrence Handle1:CAS:528:DC%2BD3sXks1WksLc%3D Occurrence Handle10.1016/S8756-3282(03)00090-5

    Article  PubMed  CAS  Google Scholar 

  7. M Haas Z Leko-Mohr P Roschger J Kletzmayr C Schwarz C Domenig (2002) ArticleTitleOsteoprotegrin and parathyroid hormone as markers of high-bone turnover osteodystrophy and decreased bone mineralization in hemodialysis patients Am J Kidney Dis 39 580–586 Occurrence Handle11877577 Occurrence Handle1:CAS:528:DC%2BD38Xit1eitb0%3D Occurrence Handle10.1053/ajkd.2002.33386

    Article  PubMed  CAS  Google Scholar 

  8. G Coen P Ballanti A Balducci S Calabria MS Fischer L Jankovic et al. (2002) ArticleTitleSerum osteoprotegrin and renal osteodystrophy Nephrol Dial Transplant 17 233–238 Occurrence Handle11812872 Occurrence Handle1:CAS:528:DC%2BD38XitVSnsrw%3D Occurrence Handle10.1093/ndt/17.2.233

    Article  PubMed  CAS  Google Scholar 

  9. KB Tan J Harrop M Reddy P Young J Terrett J Emery et al. (1997) ArticleTitleCharacterization of novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells Gene 204 35–46 Occurrence Handle9434163 Occurrence Handle1:CAS:528:DyaK1cXivFWhsg%3D%3D Occurrence Handle10.1016/S0378-1119(97)00509-X

    Article  PubMed  CAS  Google Scholar 

  10. H Yasuda N Shima N Nakagawa SI Mochizuki K Yano N Fujise et al. (1998) ArticleTitleIdentity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegrin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro Endocrinology 39 1329–1337 Occurrence Handle10.1210/en.139.3.1329

    Article  Google Scholar 

  11. BS Kown S Wang N Udagawa V Haridas ZH Lee KK Kim et al. (1998) ArticleTitleTR1, a new member of the tumor necrosis factor receptor family, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption FASEB J 12 845–854

    Google Scholar 

  12. LC Hofbauer CR Dunstan TC Spelsberg BL Riggs S Khosla (1998) ArticleTitleOsteoprotegrin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines Biochem Biophys Res Commun 250 776–781 Occurrence Handle9784422 Occurrence Handle1:CAS:528:DyaK1cXmsF2qtr4%3D Occurrence Handle10.1006/bbrc.1998.9394

    Article  PubMed  CAS  Google Scholar 

  13. LC Hofbauer S Kholsa CR Dunstan DL Lacey TC Spelsberg BL Riggs (1999) ArticleTitleEstrogen stimulates gene expression and protein production of osteoprotegrin in human osteoblastic cells Endocrinology 140 4367–4370 Occurrence Handle10465311 Occurrence Handle1:CAS:528:DyaK1MXlslSqsLw%3D Occurrence Handle10.1210/en.140.9.4367

    Article  PubMed  CAS  Google Scholar 

  14. T Murakami M Yamamoto M Yamamoto K Ono M Nishikawa N Nagata et al. (1998) ArticleTitleTransforming growth factor-β1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteocleast-like cells Biochem Biophys Res Commun 252 747–752 Occurrence Handle9837778 Occurrence Handle1:CAS:528:DyaK1cXnvF2gt7Y%3D Occurrence Handle10.1006/bbrc.1998.9723

    Article  PubMed  CAS  Google Scholar 

  15. NOA Vidal H Brändström KB Jonsson C Ohlsson (1998) ArticleTitleOsteoprotegrin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids J Endocrinol 159 191–195 Occurrence Handle9795357 Occurrence Handle1:CAS:528:DyaK1cXmsFOnurs%3D Occurrence Handle10.1677/joe.0.1590191

    Article  PubMed  CAS  Google Scholar 

  16. H Brändström KB Jonsson C Oflsson O Vidal S Ljunghall Ö Ljunggren (1998) ArticleTitleRegulation of osteoprotegrin mRNA levels by prostaglandin E2 in human bone marrow stroma cells Biochem Biophys Res Commun 247 338–341 Occurrence Handle9642127 Occurrence Handle10.1006/bbrc.1998.8783

    Article  PubMed  Google Scholar 

  17. HL Tan G Van S Scully G Shimamoto M Kelley B Boyle et al. (1997) ArticleTitleRecombinant osteoprotegrin (OPG), a novel TNF-receptor family member, inhibits in vitro murine osteoclast formation from bone marrow precursors (abstract P213) J Bone Miner Res 12 IssueID1 Suppl S155

    Google Scholar 

  18. Y Hakeda Y Kobayashi K Yamaguchi H Yasuda E Tsuda K Higashio et al. (1998) ArticleTitleOsteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts Biochem Biophys Res Commun 251 796–801 Occurrence Handle9790989 Occurrence Handle1:CAS:528:DyaK1cXntlaisbc%3D Occurrence Handle10.1006/bbrc.1998.9523

    Article  PubMed  CAS  Google Scholar 

  19. T Akatsu T Murakami M Nishikawa K Ono N Shinomiya E Tsuda et al. (1998) ArticleTitleOsteoclastogenesis-inhibitory factor supresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast Biochem Biophys Res Commun 250 229–234 Occurrence Handle9753612 Occurrence Handle1:CAS:528:DyaK1cXmt1ygs7Y%3D Occurrence Handle10.1006/bbrc.1998.9294

    Article  PubMed  CAS  Google Scholar 

  20. K Fuller B Wong S Fox Y Choi TJ Chambers (1998) ArticleTitleTRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts J Exp Med 188 997–1001 Occurrence Handle9730902 Occurrence Handle1:CAS:528:DyaK1cXmtVagtb8%3D Occurrence Handle10.1084/jem.188.5.997

    Article  PubMed  CAS  Google Scholar 

  21. MC Faugere M Langub HH Malluche (2001) ArticleTitleThe effects of PTH-(1-84) on bone turnover are antagonized by PTH-(7-84) in thyroparathyroidectomized and nephrectomized rats Abstr J Am Soc Nephrol 12 764A

    Google Scholar 

  22. L Nguyen-Yamamoto L Rousseau JH Brossard R Lepage P D’Amur (2001) ArticleTitleSynthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionised calcium concentration in rats by acting on receptor different from the PTH/PTH-related peptide receptor Endocrinology 142 1386–1392 Occurrence Handle11250917 Occurrence Handle1:CAS:528:DC%2BD3MXitlemtLg%3D Occurrence Handle10.1210/en.142.4.1386

    Article  PubMed  CAS  Google Scholar 

  23. P Divieti MR John H Juppner FR Bringhurst (2002) ArticleTitleHuman PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor Endocrinology 143 171–176 Occurrence Handle11751606 Occurrence Handle1:CAS:528:DC%2BD38XjtVOqsA%3D%3D Occurrence Handle10.1210/en.143.1.171

    Article  PubMed  CAS  Google Scholar 

  24. Cantor T. The clinical application of cyclase activating PTH assay and the inhibitor ratio. 23rd Annual Conference on Peritoneal Dialysis 2003 Mar 2–4; Seattle. Columbia: School of Medicine––University of Missouri, 2003

  25. Amerling R. What is the 3rd generation PTH assay and how do 3rd generation assays differ? 24th Annual Conference on Peritoneal Dialysis 2004 Feb 9–11; San Antonio. Columbia: School of Medicine––University of Missouri, 2004

  26. MC Monier-Faugere Z Geng H Mawad RM Friedler P Gao TL Cantor et al. (2001) ArticleTitleImproved assessment of bone turnover by the PTH- (1-84) / large C-PTH fragments ratio in ESRD patients Kidney Int 60 1460–1468 Occurrence Handle11576360 Occurrence Handle1:CAS:528:DC%2BD3MXnsFSju7o%3D Occurrence Handle10.1046/j.1523-1755.2001.00949.x

    Article  PubMed  CAS  Google Scholar 

  27. MC Faugere Z Geng H Mawad RM Friedler P Gao T Cantor et al. (2001) ArticleTitleImproved assessment of bone turnover by the PTH 1-84/large C-PTH fragments ratio in ESRD patients Kidney Int 60 460–468

    Google Scholar 

  28. Cantor T. What to look assessing the value of existing or new PTH test. 24th Annual Conference on Peritoneal Dialysis 2004 Feb 9–11; San Antonio. Columbia: School of Medicine––University of Missouri, 2004

  29. P Gao S Scheibel P D’Amur MR John SD Rao H Schmidt-Gayk et al. (2001) ArticleTitleDevelopment of the novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function J Bone Miner Res 16 605–614 Occurrence Handle11315988 Occurrence Handle1:CAS:528:DC%2BD3MXislCksbg%3D Occurrence Handle10.1359/jbmr.2001.16.4.605

    Article  PubMed  CAS  Google Scholar 

  30. AE Grzegorzewska M Młot (2004) ArticleTitleRatio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease Ann Acad Med Bialostocensis 49 190–192 Occurrence Handle1:CAS:528:DC%2BD2MXks1GisQ%3D%3D

    CAS  Google Scholar 

  31. Spiechowicz U, Kokot F, Więcek A. Function of parathyroid glands in kidney transplant patients––diagnostic value of CAP and CIP. Abstr The 2nd Poland–Korea Seminar on Renal Replacement Therapy Seoul 2004;p21

  32. S Trofimov IA Pantsulaia E Kobyliansky G Livshits (2004) ArticleTitleCirculating levels of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin/macrophage-colony stimulating factor in a presumably healthy human population Eur J Endocrinol 150 305–311 Occurrence Handle15012615 Occurrence Handle1:CAS:528:DC%2BD2cXivFCktrk%3D Occurrence Handle10.1530/eje.0.1500305

    Article  PubMed  CAS  Google Scholar 

  33. D Grigorie E Neacsu M Marinescu O Popa (2003) ArticleTitleCirculating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis Rom J Intern Med 41 409–415 Occurrence Handle15526523 Occurrence Handle1:CAS:528:DC%2BD2cXntVels70%3D

    PubMed  CAS  Google Scholar 

  34. KW Oh EJ Rhee WY Lee SW Kim ES Oh KH Baek et al. (2004) ArticleTitleThe relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women Clin Endocrinol (Oxf) 61 244–249 Occurrence Handle1:CAS:528:DC%2BD2cXnslWlt7o%3D Occurrence Handle10.1111/j.1365-2265.2004.02090.x

    Article  CAS  Google Scholar 

  35. G Schett S Kiechl K Redlich F Oberhollenzer S Weger G Egger et al. (2004) ArticleTitleSoluble RANKL and risk of nontraumatic fracture JAMA 291 1108–1113 Occurrence Handle14996780 Occurrence Handle1:CAS:528:DC%2BD2cXhvFenurc%3D Occurrence Handle10.1001/jama.291.9.1108

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, Transplantology and Internal Diseases, Karol Marcinkowski University of Medical Sciences, Poznań, Poland

    Alicja E. Grzegorzewska & Monika Młot

Authors
  1. Alicja E. Grzegorzewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monika Młot
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alicja E. Grzegorzewska.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grzegorzewska, A.E., Młot, M. Serum markers of bone turnover in dialyzed patients separated according to age. Int Urol Nephrol 38, 311–316 (2006). https://doi.org/10.1007/s11255-006-0079-1

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-006-0079-1

Keywords

Search

Navigation